IONIQ Sciences is a cutting-edge healthcare company based in Salt Lake City, UT, dedicated to revolutionizing early stage cancer detection. Their innovative digital platform combines Electrical Impedance Analytics (EIA) and Artificial Intelligence (AI) to non-invasively scan for cancer in its earliest, most-treatable stages. With a growing clinical evidence library and a team of passionate problem solvers, IONIQ Sciences aims to make early cancer detection an integral part of annual wellness checks, ultimately eliminating the fear and financial burden associated with cancer.
IONIQ Sciences is following a strategic course to modernize early stage cancer detection by commercializing breakthrough devices such as the IONIQ ProLung Test and the IONIQ Breast Test. With the goal of developing and commercializing the first ever FDA cleared Multi-Cancer Screen, IONIQ Sciences is committed to amassing valuable clinical data and making a lasting contribution to the world by conquering the challenges of early detection.
Generated from the website